MissionIR Articles

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager (“BiTAC-TCE”) program through a collaboration with ATUM, which will apply its Leap-In Transposase(R) technology to generate stable clonal cell lines supporting IND/CTA-enabling activities and future clinical development. The collaboration follows encouraging preclinical data presented at the 2026 American Association for…

Wrap Technologies (NASDAQ: WRAP) announced that the University of Maryland, Baltimore County has purchased BolaWrap(R) devices and Non-Lethal Response training as part of its initial deployment of non-lethal capabilities for campus safety and security. The company said the deployment is intended to support responsible, measured response by providing officers with an additional non-lethal tool designed to help reduce escalation and create opportunities for…

SS Innovations International (NASDAQ: SSII) was named Outstanding Company at the 2026 Surgical Robotics Industry Awards, surpassing finalists:  The award recognizes a single company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact. About SS Innovations  SS Innovations International, Inc. (NASDAQ: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and…

RoboStrategy (NASDAQ: BOT) announced the completion of a series of private share issuances to institutional investors conducted between June 26 and June 29, 2026. The registered closed-end fund issued 1,346,668 shares of common stock at a weighted average price of $25.17 per share, generating gross proceeds of approximately $33.9 million before offering expenses. The fund said it…

SS Innovations International (NASDAQ: SSII) announced it has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, which recognizes a company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact. The company said the award reflects growing adoption of its SSi Mantra surgical robotic system, which it believes is gaining traction for its…

AMC (NYSE: AMC) announced the closing of its previously announced registered direct offering of 95.25 million shares of common stock, generating approximately $200 million in gross proceeds before fees and expenses. The company said it intends to use the proceeds primarily to redeem all $125.47 million of its 6.125% Senior Subordinated Notes due 2027, eliminating any anticipated material debt principal repayments before…

VolitionRx Limited (NYSE American: VNRX) announced a collaboration with Sysmex (TYO: 6869) to optimize Volition’s Nu.Q® NETs H3.1 assay on the Sysmex diagnostic platform. The agreement supports Volition’s strategy of licensing its proprietary Nu.Q® NETs technology to established global diagnostics companies that can leverage their disease expertise, regulatory capabilities and installed analyzer base to accelerate development and commercialization. Volition said the collaboration has progressed beyond assay transfer and…

SpaceX (NASDAQ: SPCX) briefly surpassed Amazon.com in market capitalization on June 16 as investors continued piling into shares following the company’s record-setting initial public offering, according to a Reuters report. Reuters reported that shares of Elon Musk’s rocket, satellite and artificial intelligence company climbed as much as 10%, pushing its valuation above $2.7 trillion and, at one point, ahead of both Amazon…

Humacyte (NASDAQ: HUMA) announced the pricing of an underwritten public offering of 47.6 million shares of common stock at $1.05 per share, with expected gross proceeds of approximately $50 million before underwriting discounts, commissions and offering expenses. The company also granted underwriters a 30-day option to purchase up to an additional 7.1 million shares at the public offering price. The offering is expected…